Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VALEANT PHARMACEUTICALS INTL Financial Overview

  • Income Statement: VRX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 656.98 M 689.50 M -32.53 M -4.95%
    Gross Profit 439.09 M 475.46 M -36.37 M -8.28%
    Net Income Before Extra Items/Preferred Div -23.71 M -6.19 M -17.53 M 73.91%
    Operating Income 74.10 M 85.50 M -11.40 M -15.38%
  • Cash Flow: VRX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -475.00 M -93.32 M -381.69 M 80.35%
    Net Cash Flow - Investing -169.92 M 39.34 M -209.26 M 123.15%
    Net Cash Flow/Operating Activities 216.53 M 92.52 M 124.01 M 57.27%
  • Balance Sheet: VRX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 1.17 B 1.44 B -262.87 M -22.42%
    Total Liabilities 969.08 M 1.02 B -52.20 M -5.39%
    Shareholders Equity 203.42 M 414.10 M -210.68 M -103.57%
  • Key Ratios / Statistics: VRX

    • Valuation

      Price/Earnings (TTM) -10.55
      Price/Sales (TTM) 3.05
      Price/Book (MRQ) 6.76
      Price/Cash Flow (TTM) 14.33
    • Profitability

      Gross Margin 66.83
      Operating Margin 11.28
      Profit Margin -3.61
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.24
      Current Ratio (MRQ) 1.58
      Long Term Debt-to-Equity (MRQ) 163.68
    • Management Effectiveness

      Return on Equity (TTM) -60.90
      Return on Assets (TTM) -3.23
      Return on Investments (TTM) -0.42